LncRNA PTENP1 Inhibits Cervical Cancer Progression by Suppressing MiR-106b
Overview
Biotechnology
Authors
Affiliations
LncRNA PTENP1 is a competitive endogenous RNA (ceRNA) involved in decoying miR-106b in multiple diseases. This study investigates the interaction of PTENP1 and miR-106b in cell proliferation, apoptosis and epithelial-mesenchymal transition (EMT) in cervical cancer. The expressions of PTENP1, miR-106b and PTEN were determined in cervical cancer tissues, adjacent normal tissues, cervical cancer cells (HeLa, SiHa, C33A and CasKi) and normal cervical epithelial H8 cells. Up-regulation of PTENP1 and down-regulation of miR-106b were conducted in HeLa and CasKi cells by transfecting cells with corresponding miRNA mimics and inhibitors. Bioinformatics analysis, luciferase reporter assay and RNA-pull down assay were performed to verify the association of miR-106b, PTEN, and PTENP1. Cell growth and cell apoptosis were determined by CCK-8 and flow cytometry analysis. It was found that the expressions of PTENP1 and PTEN were up-regulated and that of miR-106b were down-regulated in cervical cancer tissues and cells. PTENP1 localized in cytoplasm and competitively bound to miR-106b. Up-regulation of PTENP1 and down-regulation of miR-106b contributed to increased expressions of PTEN and E-cadherin. Decreased expression of miR-106b, ZEB1, Snail and Vimentin, resulted in inhibiting cell proliferation and promoting cell apoptosis. Over-expression of PTENP1 and miR-106b accelerated cell proliferation and slowed down cell apoptosis. miR-106b inhibited the expression of PTEN. Our results suggest that LncRNA PTENP1 inhibits cervical cancer progression by competitively binding to miR-106b, leading to promote PTEN expression, inhibit cell proliferation and EMT and induce cell apoptosis in cervical cancer cells.
A fishnet between nasopharyngeal carcinoma and resistance: the competing endogenous RNA network.
Li M, Mo T, Yang Z, Yao Y, Wang Y, Zhao Y Curr Treat Options Oncol. 2025; 26(1):45-54.
PMID: 39810047 DOI: 10.1007/s11864-024-01284-3.
The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression.
Gu Z, Zou L, Pan X, Yu Y, Liu Y, Zhang Z MedComm (2020). 2024; 5(12):e70026.
PMID: 39640362 PMC: 11617596. DOI: 10.1002/mco2.70026.
GRASLND regulates melanoma cell progression by targeting the miR-218-5p/STAM2 axis.
Ma A, Shi W, Chen L, Huang Z, Zhang Y, Tang Z J Transl Med. 2024; 22(1):684.
PMID: 39060946 PMC: 11282654. DOI: 10.1186/s12967-024-05397-z.
Guo M, Guo D, Liao L, Zhang X, Wang Z, Zhou Q BMC Complement Med Ther. 2024; 24(1):212.
PMID: 38831394 PMC: 11149180. DOI: 10.1186/s12906-024-04502-5.
Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer.
Safavi P, Moghadam K, Haghighi Z, Ferns G, Rahmani F Curr Pharm Des. 2024; 30(5):352-361.
PMID: 38303530 DOI: 10.2174/0113816128284380240123071409.